Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi SurgicalTecnologist I don't do the bookface, I just asked to become a follower of your Titan medical information group, my immaturity precedes my intellect and if you could please add sirfartalot It would be greatly appreciated
What about the folks not on the bookface??? Anyway to share the content??
BUY OUT?
2011 Titan Medical Operational Highlights
TORONTO, ONTARIO--(Marketwire – August 16, 2011) – Titan Medical Inc. ("Titan” or the “Company") (TSX VENTURE: TMD) announced today results for the three and six months ended June 30, 2011.
The financial statements and Management’s Discussion and Analysis for the period may be viewed on SEDAR.
Craig Leon, Chief Executive Officer of Titan Medical Inc., said, “The momentum created in the first quarter has carried over into the second quarter and we are very proud of our accomplishments to date. We established several industry leading relationships, including Crouse Hospital, Mayo Clinic and Sense Graphics, which enable us to proceed with development and testing of Amadeus ComposerTM. We also successfully raised $9.2 million, which provides us with sufficient funds to continue development of our next generation robotic surgical system during the second half of 2011.”
Operational Highlights
• Entered into an exclusive patent license agreement with Mayo Foundation for Medical Education and Research for its novel surgical stapler.
• Signed a development agreement with D&D Video Specialists, Inc. (D2 VideoTM), a leading developer of endoscopic vision systems. D2 VideoTM will design and develop a proprietary vision system for Amadeus ComposerTM.
• Appointed Dr. John R. Valvo, M.D., F.A.C.S. as Vice President of Medical Affairs.
• Appointed Dr. Carlo Camargo Passerotti, M.D., PhD and Dr. Li-Ming Su, M.D. to the Company's Medical Advisory Board.
• Signed a non-binding memorandum of understanding with Crouse Hospital, Inc., a 506-bed acute care hospital in Syracuse, NY. Crouse Hospital will test and evaluate Amadeus Composer TM.
• Announced positive testing results for its Beta Console early user study.
• Signed a development agreement with Proven Process Medical Devices, Inc. ("Proven Process"), a leading provider of medical device contract research and development, and manufacturing services. Proven Process will develop certain
proprietary components of Amadeus Composer TM.
Sounds like Titan Medical to a T
Renee Ryan, Vice President of Venture Investments, Johnson & Johnson Innovation – JJDC (JJDC), is focused on maximizing investments in MedTech innovation that have the greatest potential to advance patient care.
How has the Medical Devices landscape evolved over time, and what do you believe the future of Medical Devices will look like five years from now?
Over the last 20 years, we’ve been able to pivot from invasive technologies and less specific diagnostic tools to now evolve them to incredible solutions that change the paradigm of how we treat patients.
From my perspective, I think we will see a trend towards less invasive and minimally invasive technologies with increased benefit to the overall healthcare system – not only increased benefit for the clinician but increased benefit for the patient, payer and provider all in one.
- See more at: https://talk.jnjinnovation.com/article/sourcing-meaningful-innovation-medical-devices#sthash.bnkMD5fK.dpuf
Renee Ryan, Vice President of Venture Investments, Johnson & Johnson Innovation – JJDC (JJDC), is focused on maximizing investments in MedTech innovation that have the greatest potential to advance patient care.
What are the top three things you look for when investing in a medical device company?
1. Great team – With a great leader that has the ability to inspire others.
2. Breakthrough innovation – Not just an iteration of what already exists.
3. Patient benefit – Solutions that advance patient care.
- See more at: https://talk.jnjinnovation.com/article/sourcing-meaningful-innovation-medical-devices#sthash.bnkMD5fK.dpuf
Interesting that J&J innovations labs is a premier sponsor at the Bloom Burton conference, coincidence? I'm hoping not
Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, and listed on the Toronto Stock Exchange (TMD) and on the OTCQX in the United States (TITXF).
Titan is developing the SPORT™ Surgical System for use in minimally invasive surgery (“MIS”). The SPORT™ Surgical System is expected to be commercially available in late 2016 in Europe and in mid-2017 in the United States.
The SPORT™ Surgical System consists of:
An innovative, surgeon-controlled robotic platform that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and
A surgeon workstation that provides the surgeon with an advanced ergonomic interface to the robotic platform for controlling the instruments, as well as a 3D view inside the patient’s body cavity during MIS procedures.
The robotic technology currently available on the market is cost prohibitive for secondary and tertiary hospitals, as well as for ambulatory surgery centers, and is confined to a limited number of surgical procedures, such as hysterectomies and prostatectomies. Titan’s highly differentiated SPORT™ Surgical System is being designed to expand robotic surgery into areas that are currently underserved, including general abdominal, gynecologic, and urologic procedures, in a cost-effective manner.
On December 21, 2015, Titan announced the completion of the initial SPORT™ Surgical System for use in engineering verification to measure performance in relation to design specifications and to measure compliance with regulatory guidelines. This initial build of the surgical system is a precursor of the systems that will be built in early 2016 for first-in-human trials.
Development of the SPORT™ Surgical System has proceeded in response to “voice of customer” feedback and in consultation medical technology development firms engaged by Titan and the Titan’s Surgeon Advisory Board comprised of world-renowned surgeons affiliated with leading institutions, including Columbia University, Mayo Clinic, and UCLA.
If it shows up in red does that mean they sold 500,000 of their shares?? Or is that a buy of 500,000??
If it's a sell that's a bad thing yes??
Dang new low .62 f!
With hold the charge
Hold hoooooold hoooooooooold
Agree with cuin, this is not mako and limited procedures, this is the key that unlocks hundreds of surgery applications with minimum cost to third party, this is a whale in terms of a market and procedure
Three Looks side by side:
Transenterix
That's pie in the sky could see a 10 for 1 merger
Influence the brightest with the brightest, was told Titan gonna be bought out by Intuitive, 2 for 1 deal
Valvo leaves an annual 300k position for a company he's gonna make millions with, buckle up investors shits bout to get real
Titan purchased this vehicle for Dr V
http://www.volvocars.com/us/cars/new-models/xc90-t8-twin-engine
Key takeaways
Rochester General Hospital, ranked among the top one percent of hospitals nationally for robotic surgery volume
John Valvo, MD, director of robotic surgery for Rochester General “As a national leader in robotic surgery for more than a decade, innovation has been integral to our success,”
Have a friend who knows Dr. John Valvo personally through many acquaintances via Olympus medical in the OR
this is old board news but about two months ago he told me John Valvo has left his personal practice and is working full-time with Titan he also told me Titan Medical purchased him a 70k Volvo SUV
Yes jet how do we see that post, I'm following Titan and am interested to see the Valvo remarks but don't know where to look
Titan Medical Inc. Announces Completion of First SPORT™ Surgical System
TORONTO, ON--(Marketwired - December 21, 2015) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQX: TITXF) today announced that it has built the initial SPORT™ Surgical Systems to include both the work station and the patient cart and will undergo extensive testing as a part of Engineering Verification (EV). These two EV systems will be tested to measure performance in relation to design specifications and to measure compliance with regulatory guidelines. These EV systems are precursors of the systems that will be built in early 2016 for first-in-human trials.
Dennis Fowler, EVP, Clinical and Regulatory Affairs, stated, "This fully integrated initial EV system represents the efforts of many people at Titan, our Surgeon Advisory Board and our development contractors. This is a major accomplishment for Titan as we move toward our first-in-human trials."
John Hargrove, Chairman and CEO of Titan Medical Inc., commented, "I am very pleased and excited that we are able to finish off the year with such a positive accomplishment. I would encourage readers to visit our web site at www.titanmedicalinc.com where we have posted pictures of this complete initial SPORT Surgical System."
http://www.bloomberg.com/news/articles/2015-12-10/j-j-verily-life-sciences-create-new-robotic-surgery-company
The partnership was designed to advance a prototype that J&J, the world’s largest maker of health-care products, developed as the core of a new robotic surgical system.
Question to the board, when Titan got funded earlier in 2014, if this possibly was jnj, it wouldn't make sense to have Sri international and Ximedica as engineers right??
Does this rule out Titan as the JNJ platform??
How is that not malpractice on the Doctor using the device? Saturday night live should to a comedy skit on that article, it's funny but you can't laugh
At 4 o'clock on the dot JNJ had a 789,000 share sale equivalent to 78,900,000 dollars. I'm hoping that sale has something to do with Titan
No product no sales
Verbs Mission statement sounds very similar to Titans
Creating the Future of Surgery
Verb Surgical™ is working with physicians around the world to create the future of surgery. A new future, a future unimagined even a few years ago, which will involve machine learning, robotic surgery, instrumentation, advanced visualization, and data analytics. A future of surgery that aims to achieve improved patient outcomes, lower costs, and greater hospital efficiency.
http://www.verbsurgical.com/about-us/
Titan’s Surgeon Advisory Board is comprised of world-renowned surgeons affiliated with leading institutions, including Columbia University, Mayo Clinic, and UCLA. Additionally, the Company has established partnerships with academic institutions and hospitals across the globe, including Rochester General Hospital, University of Florida, Children’s Hospital Boston, Apollo Hospital Group (India), and The Ohio State University.
The robotic technology currently available on the market is cost prohibitive for secondary and tertiary hospitals, as well as for Ambulatory Surgery Centers, and is confined to a limited number of surgical procedures, such as hysterectomies and prostatectomies. Titan’s highly differentiated SPORT™ Surgical System is being designed to expand robotic surgery into areas that are currently underserved, including general abdominal, gynecologic, and urologic procedures, in a cost-effective manner.
Verb Surgical Press Releases
http://www.verbsurgical.com/media/
Nabil Simaan is listed as co author of that patent
http://news.columbia.edu/content/using-robots-less-invasive-surgery
Looks like there are cross over between Andrea Bajo's work and Titan
http://www.medicaldevice-network.com/news/newstitan-medical-columbia-university-to-develop-single-port-robotic-surgery-system
Interesting connection: SRI and Intuitive???
SRI has a long history in the field of medical robotics, in particular through its pioneering telepresence technologies. In 1995, SRI spun off Intuitive Surgical, Inc. to commercialize its revolutionary robotic surgical technology. More recently, SRI’s M7 telesurgical robot conducted the first robotic surgery demonstration in a simulated zero-gravity environment, and was part of an experiment last year involving multiple biomedical robots manipulated from different locations. The M7 represents the next generation of telesurgical capabilities from SRI that leverage the organization’s comprehensive portfolio of expertise, which includes stereo imaging, telerobotics, sensory devices, video, speech recognition, and telecommunications, to perform monitoring, actual operations, and assistance-related activities from remote locations in real time. - See more at: https://www.sri.com/newsroom/press-releases/sri-international-demonstrate-dexterous-telesurgical-robot-block-party-event#.dpuf
May just be me but if you look at SRI Internationals M7 robot looks very similar to Titans, please see below each link.
https://www.sri.com/engage/products-solutions/m7-surgical-robot
Titans robot
http://www.cantechletter.com/2014/04/robotic-surgery-hopeful-titan-medical-looks-raise-22-million/
I want the boards opinion
Bristol you think it's sport that JNJ is bringing to the partnership?
It’s also still a bit vague at this point what, exactly, Verb Surgical will be working on. “In the coming years, Verb aims to develop a comprehensive surgical solutions platform that will incorporate leading-edge robotic capabilities and best-in-class medical device technology for operating room professionals,” the press release reads. While that sounds like it has potential, it hardly paints a picture of how Verb is imagining the surgical room of the future. Are they setting out to design brand new tools from scratch? Will they improve on the tools that already exist?
According to the press release announcing Verb, the company will be based in Google’s hometown of Mountain View, California. While it’s confirmed that both Johnson & Johnson and Verily have an equity investment in Verb Surgical, additional financial terms haven’t been publicly disclosed. Both J&J and Verily do say they’ve contributed intellectual property, research and development, and other resources—including managerial and surgical expertise—to Verb Surgic
The three colored T logo on screen and console represents a three company partnership imo
http://www.titanmedicalinc.com/investor-relations/sport-clips-pictures/
This ignore list is brilliant
Any nuggets from the robotic conference today investinthefuture???
I agree Titan, Alan Conor President of Cadence comes from an engineering background at Penn State University
My early career experience included manufacturing, quality and project engineering and supply chain consulting. I also have about 15 years of experience in a variety of management roles within large and medium-sized medical device companies, including supply chain management, manufacturing, marketing and new product development. I joined Cadence as President in 2011 to help continue
http://www.cadencedevice.com/about/our-team/
Dennis Fowler to present day one
SURGICAL ROBOTICS: OPPORTUNITIES IN A COMPETITIVE LANDSCAPE
Day 1 | 10:00 - 11:30 AM
Marie Calabria, VP of Operations,
Blue Belt Technologies; Dennis Fowler, Executive Vice President, Titan Medical Inc.
SURGICAL ROBOTICS: OPPORTUNITIES IN A COMPETITIVE LANDSCAPE
Day 1 | 10:00 - 11:30 AM
Marie Calabria, VP of Operations,
Blue Belt Technologies; Dennis Fowler, Executive Vice President, Titan Medical Inc.